foscarnet has been researched along with Eye Infections, Viral in 59 studies
Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.
Eye Infections, Viral: Infections of the eye caused by minute intracellular agents. These infections may lead to severe inflammation in various parts of the eye - conjunctiva, iris, eyelids, etc. Several viruses have been identified as the causative agents. Among these are Herpesvirus, Adenovirus, Poxvirus, and Myxovirus.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a controlled trial of foscarnet in the treatment of cytomegalovirus (CMV) retinitis in patients with the acquired immunodeficiency syndrome (AIDS), patients with non-immediately sight-threatening lesions were randomized to receive immediate treatment with foscarnet or foscarnet treatment delayed until the first signs of retinitis progression." | 9.07 | Design of a randomized controlled trial of foscarnet in patients with cytomegalovirus retinitis associated with acquired immunodeficiency syndrome. ( Polis, MA, 1992) |
| "To evaluate foscarnet sodium in treating cytomegalovirus retinitis in patients with AIDS." | 9.07 | A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. ( Baird, BF; Davey, RT; Davis, M; De Smet, MD; Falloon, J; Kovacs, JA; Palestine, AG; Polis, MA; Zunich, KM; Zurlo, JJ, 1991) |
| "The use of ganciclovir in the treatment of cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS) is limited by marrow toxicity and by the development of resistance to this agent in CMV strains capable of causing progressive disease." | 8.78 | Maintenance therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: foscarnet. ( Jacobson, MA, 1992) |
| "To report use of intravenous foscarnet or cidofovir for the treatment of refractory acute retinal necrosis (ARN)." | 7.88 | Treatment of Refractory Acute Retinal Necrosis with Intravenous Foscarnet or Cidofovir. ( Barshak, MB; Durand, ML; Foster, CS; Kim, IK; Mali, JO; Scott, NL; Stryjewski, TP; Tobin, EH; Young, LH, 2018) |
| "To study the effects of intravitreal foscarnet and the clinical differences between varicella zoster virus (VZV) and herpes simplex virus (HSV) induced acute retinal necrosis (ARN)." | 7.76 | Acute retinal necrosis: the effects of intravitreal foscarnet and virus type on outcome. ( Graham, EM; Laidlaw, DA; Pavesio, CE; Stanford, MR; Williamson, TH; Wong, R, 2010) |
| "Infections caused by cytomegalovirus (CMV) resistant in vitro to ganciclovir, defined as requiring greater than 6 mumols of ganciclovir for ED50 have developed in some AIDS patients with progressive CMV retinitis despite chronic ganciclovir therapy." | 7.68 | Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS. ( Drew, WL; Feinberg, J; Jacobson, MA; Miner, RD; O'Donnell, JJ; Parenti, D; Whitmore, PV, 1991) |
| "Foscarnet is an investigational antiviral agent that has been used effectively in the treatment of cytomegalovirus (CMV) retinitis in AIDS patients." | 7.68 | Successful foscarnet therapy for cytomegalovirus retinitis in an AIDS patient undergoing hemodialysis: rationale for empiric dosing and plasma level monitoring. ( Gambertoglio, JG; Graziani, AL; Grunwald, JE; MacGregor, RR; Weiss, R, 1991) |
| "Foscarnet has a low solubility and a high degree of ionization at physiologic pH, requiring it to be administered in higher doses and larger volumes." | 6.38 | Approaches to the treatment of cytomegalovirus retinitis: ganciclovir and foscarnet. ( Jacobson, MA; O'Donnell, JJ, 1991) |
| "We treated a patient who had acquired immunodeficiency syndrome and cytomegalovirus retinitis of the left eye." | 5.28 | Intravitreal foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome. ( Chipont, E; Díaz-Llopis, M; España, E; Menezo, JL; Navea, A; Sanchez, S, 1992) |
| "After withdrawal from maintenance treatment, a relapse of cytomegalovirus retinitis occurred, which was again successfully treated with ganciclovir." | 5.28 | 2.5 years survival with sequential ganciclovir/foscarnet treatment in a patient with acquired immune deficiency syndrome and cytomegalovirus retinitis. ( Geier, SA; Goebel, FD; Klauss, V; Kronawitter, U; Matuschke, A, 1992) |
| "In a controlled trial of foscarnet in the treatment of cytomegalovirus (CMV) retinitis in patients with the acquired immunodeficiency syndrome (AIDS), patients with non-immediately sight-threatening lesions were randomized to receive immediate treatment with foscarnet or foscarnet treatment delayed until the first signs of retinitis progression." | 5.07 | Design of a randomized controlled trial of foscarnet in patients with cytomegalovirus retinitis associated with acquired immunodeficiency syndrome. ( Polis, MA, 1992) |
| "To evaluate foscarnet sodium in treating cytomegalovirus retinitis in patients with AIDS." | 5.07 | A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. ( Baird, BF; Davey, RT; Davis, M; De Smet, MD; Falloon, J; Kovacs, JA; Palestine, AG; Polis, MA; Zunich, KM; Zurlo, JJ, 1991) |
| "The use of ganciclovir in the treatment of cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS) is limited by marrow toxicity and by the development of resistance to this agent in CMV strains capable of causing progressive disease." | 4.78 | Maintenance therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: foscarnet. ( Jacobson, MA, 1992) |
| "Acute retinal necrosis secondary to HSV-2 tended to have persistent active retinitis with a higher rate of retinal detachment despite similar treatment protocols, suggesting that in some cases combination intravenous acyclovir and adjuvant intravitreal foscarnet injections are not sufficient." | 4.02 | ACUTE RETINAL NECROSIS: Difference in Outcome by Viral Type and Options for Antiviral Therapy. ( Botsford, BW; Eller, AW; Nguyen, VQ, 2021) |
| "To report use of intravenous foscarnet or cidofovir for the treatment of refractory acute retinal necrosis (ARN)." | 3.88 | Treatment of Refractory Acute Retinal Necrosis with Intravenous Foscarnet or Cidofovir. ( Barshak, MB; Durand, ML; Foster, CS; Kim, IK; Mali, JO; Scott, NL; Stryjewski, TP; Tobin, EH; Young, LH, 2018) |
| "To study the effects of intravitreal foscarnet and the clinical differences between varicella zoster virus (VZV) and herpes simplex virus (HSV) induced acute retinal necrosis (ARN)." | 3.76 | Acute retinal necrosis: the effects of intravitreal foscarnet and virus type on outcome. ( Graham, EM; Laidlaw, DA; Pavesio, CE; Stanford, MR; Williamson, TH; Wong, R, 2010) |
| "Sequential visual field testing is an extremely helpful adjunct to ophthalmoscopy and fundus photography in the management of cytomegalovirus (CMV) retinitis with the antiviral agents ganciclovir or foscarnet in patients with the acquired immune deficiency syndrome (AIDS)." | 3.68 | Visual field testing in the management of cytomegalovirus retinitis. ( Bachman, DM; Bruni, LM; DiGioia, RA; Harris, PJ; McMackin, CM; Pistole, MC; Thomas, RM; Ward, DJ, 1992) |
| "Infections caused by cytomegalovirus (CMV) resistant in vitro to ganciclovir, defined as requiring greater than 6 mumols of ganciclovir for ED50 have developed in some AIDS patients with progressive CMV retinitis despite chronic ganciclovir therapy." | 3.68 | Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS. ( Drew, WL; Feinberg, J; Jacobson, MA; Miner, RD; O'Donnell, JJ; Parenti, D; Whitmore, PV, 1991) |
| "Foscarnet is an investigational antiviral agent that has been used effectively in the treatment of cytomegalovirus (CMV) retinitis in AIDS patients." | 3.68 | Successful foscarnet therapy for cytomegalovirus retinitis in an AIDS patient undergoing hemodialysis: rationale for empiric dosing and plasma level monitoring. ( Gambertoglio, JG; Graziani, AL; Grunwald, JE; MacGregor, RR; Weiss, R, 1991) |
| "Foscarnet has a low solubility and a high degree of ionization at physiologic pH, requiring it to be administered in higher doses and larger volumes." | 2.38 | Approaches to the treatment of cytomegalovirus retinitis: ganciclovir and foscarnet. ( Jacobson, MA; O'Donnell, JJ, 1991) |
| " Myelosuppression may be further exacerbated in AIDS patients by such other agents as zidovudine or trimethoprim/sulfamethoxazole, often necessitating dosage reductions or discontinuation of these agents in patients receiving ganciclovir." | 2.38 | Foscarnet sodium. ( Baltz, JK; Minor, JR, 1991) |
| " While on maintenance dosing of oral valacyclovir, he experienced reactivation in the form of bilateral vasculitis, which was successfully managed once restarting therapeutic oral dosing." | 1.51 | Case Report: Varicella-zoster Encephalitis with Acute Retinal Necrosis and Oculomotor Nerve Palsy. ( Quan, SC; Skondra, D, 2019) |
| " Chronic suppression with oral antiviral therapy after ARN is recommended to prevent involvement of the contralateral eye, though there is no consensus on the duration and dosage of antivirals." | 1.51 | Acute retinal necrosis in a patient with remote severe herpes simplex encephalitis. ( Kobayashi, T; Meier, J; Sekar, P; Streit, J, 2019) |
| "Retinal detachment is the main complication." | 1.32 | [Acute retinal necrosis: clinical presentation, treatment, and prognosis in a series of 22 patients]. ( Laroche, L; Larricart, P; Metge, F; Monin, C; Morel, C; Roman, S; Scheer, S, 2004) |
| "Retinitis was clinically graded by indirect ophthalmoscopy, and the retinitis scores were compared across the treatment and control groups." | 1.30 | Treatment of herpes retinitis in an animal model with a sustained delivery antiviral drug, liposomal 1-O-octadecyl-SN-glycerol-3-phosphonoformate. ( Bergeron-Lynn, G; Chaidhawangul, S; Cheng, L; Freeman, WR; Gardner, MF; Hostetler, KY; Mach-Hofacre, B; Mueller, AJ; Ozerdem, U; Severson, GM, 1999) |
| "We treated a patient who had acquired immunodeficiency syndrome and cytomegalovirus retinitis of the left eye." | 1.28 | Intravitreal foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome. ( Chipont, E; Díaz-Llopis, M; España, E; Menezo, JL; Navea, A; Sanchez, S, 1992) |
| "After withdrawal from maintenance treatment, a relapse of cytomegalovirus retinitis occurred, which was again successfully treated with ganciclovir." | 1.28 | 2.5 years survival with sequential ganciclovir/foscarnet treatment in a patient with acquired immune deficiency syndrome and cytomegalovirus retinitis. ( Geier, SA; Goebel, FD; Klauss, V; Kronawitter, U; Matuschke, A, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 36 (61.02) | 18.2507 |
| 2000's | 8 (13.56) | 29.6817 |
| 2010's | 13 (22.03) | 24.3611 |
| 2020's | 2 (3.39) | 2.80 |
| Authors | Studies |
|---|---|
| Manikowski, A | 1 |
| Verri, A | 1 |
| Lossani, A | 1 |
| Gebhardt, BM | 1 |
| Gambino, J | 1 |
| Focher, F | 1 |
| Spadari, S | 1 |
| Wright, GE | 1 |
| Hafidi, M | 1 |
| Janin-Manificat, H | 1 |
| Denis, P | 1 |
| Charleux, B | 1 |
| Rabilloud, M | 1 |
| Boibieux, A | 1 |
| Burillon, C | 1 |
| Kodjikian, L | 1 |
| Frobert, E | 1 |
| Pockar, S | 1 |
| Jones, NP | 1 |
| Chhabra, R | 1 |
| Steeples, LR | 1 |
| Botsford, BW | 1 |
| Nguyen, VQ | 1 |
| Eller, AW | 1 |
| Ong, SS | 1 |
| Postel, EA | 1 |
| Quan, SC | 1 |
| Skondra, D | 1 |
| Kobayashi, T | 1 |
| Sekar, P | 1 |
| Meier, J | 1 |
| Streit, J | 1 |
| Or, C | 1 |
| Press, N | 1 |
| Forooghian, F | 1 |
| Dokey, AT | 1 |
| Haug, SJ | 1 |
| McDonald, HR | 1 |
| Cunningham, ET | 1 |
| Lujan, BJ | 1 |
| Fu, AD | 1 |
| Jumper, JM | 1 |
| Weissman, HM | 1 |
| Biousse, V | 1 |
| Schechter, MC | 1 |
| Del Rio, C | 1 |
| Yeh, S | 2 |
| Le, TD | 1 |
| Weisbrod, D | 1 |
| Mandelcorn, ED | 1 |
| Xu, K | 1 |
| Chin, EK | 1 |
| Mahajan, VB | 1 |
| Almeida, DR | 1 |
| Stryjewski, TP | 1 |
| Scott, NL | 1 |
| Barshak, MB | 1 |
| Tobin, EH | 1 |
| Mali, JO | 1 |
| Young, LH | 1 |
| Foster, CS | 1 |
| Kim, IK | 1 |
| Durand, ML | 1 |
| Schoenberger, SD | 1 |
| Kim, SJ | 2 |
| Thorne, JE | 1 |
| Mruthyunjaya, P | 1 |
| Bakri, SJ | 1 |
| Ehlers, JP | 1 |
| Lo, WR | 1 |
| Wong, R | 1 |
| Pavesio, CE | 1 |
| Laidlaw, DA | 1 |
| Williamson, TH | 1 |
| Graham, EM | 1 |
| Stanford, MR | 1 |
| Meghpara, B | 1 |
| Sulkowski, G | 1 |
| Kesen, MR | 1 |
| Tessler, HH | 1 |
| Goldstein, DA | 1 |
| Gain, P | 1 |
| Chiquet, C | 1 |
| Thuret, G | 1 |
| Drouet, E | 1 |
| Antoine, JC | 1 |
| Morel, C | 1 |
| Metge, F | 1 |
| Roman, S | 1 |
| Scheer, S | 1 |
| Larricart, P | 1 |
| Monin, C | 1 |
| Laroche, L | 1 |
| Tran, TH | 1 |
| Stanescu, D | 1 |
| Caspers-Velu, L | 1 |
| Rozenberg, F | 2 |
| Liesnard, C | 1 |
| Gaudric, A | 1 |
| Lehoang, P | 2 |
| Bodaghi, B | 2 |
| Oberacher-Velten, IM | 1 |
| Jonas, JB | 1 |
| Jünemann, A | 1 |
| Schmidt, B | 1 |
| de Schryver, I | 1 |
| Cassoux, N | 1 |
| Michelson, S | 1 |
| Kestelyn, P | 1 |
| Davis, JL | 1 |
| Irvine, AR | 1 |
| Freeman, WR | 3 |
| Pearson, PA | 1 |
| Jaffe, GJ | 1 |
| Ashton, P | 1 |
| Brockmeyer, NH | 1 |
| Hengge, UR | 1 |
| Mertins, L | 1 |
| Malessa, R | 1 |
| Steinmetz, R | 1 |
| Gooss, M | 1 |
| Flores-Aguilar, M | 1 |
| Kuppermann, BD | 1 |
| Quiceno, JI | 2 |
| Dankner, WM | 1 |
| Wolf, DG | 1 |
| Capparelli, EV | 1 |
| Connor, JD | 1 |
| Sherwood, CH | 1 |
| Fullerton, S | 1 |
| Gambertoglio, JG | 2 |
| Patel, SS | 1 |
| Rutzen, AR | 1 |
| Marx, JL | 1 |
| Thach, AB | 1 |
| Chong, LP | 1 |
| Rao, NA | 3 |
| Moorthy, RS | 1 |
| Weinberg, DV | 1 |
| Teich, SA | 1 |
| Berger, BB | 1 |
| Minturn, JT | 1 |
| Kumar, S | 1 |
| Fowell, SM | 1 |
| Loose, IA | 1 |
| Jampol, LM | 2 |
| Cheng, L | 1 |
| Hostetler, KY | 1 |
| Chaidhawangul, S | 1 |
| Gardner, MF | 1 |
| Ozerdem, U | 1 |
| Bergeron-Lynn, G | 1 |
| Mach-Hofacre, B | 1 |
| Mueller, AJ | 1 |
| Severson, GM | 1 |
| Chakrabarti, S | 1 |
| Collingham, KE | 1 |
| Osman, H | 1 |
| Fegan, CD | 1 |
| Milligan, DW | 1 |
| Healy, B | 1 |
| Masur, H | 1 |
| Heinemann, MH | 1 |
| Polis, MA | 2 |
| Jacobson, MA | 4 |
| Jabs, DA | 1 |
| Salit, IE | 1 |
| Wilson, RJ | 1 |
| Keefe, KS | 1 |
| Peterson, TJ | 1 |
| Wiley, CA | 1 |
| Crapotta, J | 1 |
| Listhaus, AD | 1 |
| Bachman, DM | 1 |
| Bruni, LM | 1 |
| DiGioia, RA | 1 |
| Harris, PJ | 1 |
| McMackin, CM | 1 |
| Pistole, MC | 1 |
| Thomas, RM | 1 |
| Ward, DJ | 1 |
| Díaz-Llopis, M | 1 |
| Chipont, E | 1 |
| Sanchez, S | 1 |
| España, E | 1 |
| Navea, A | 1 |
| Menezo, JL | 1 |
| Geier, SA | 1 |
| Klauss, V | 1 |
| Matuschke, A | 1 |
| Kronawitter, U | 1 |
| Goebel, FD | 1 |
| Morinelli, EN | 1 |
| Dugel, PU | 1 |
| Lee, M | 1 |
| Klatt, EC | 1 |
| Morris, DJ | 1 |
| Drew, WL | 1 |
| Feinberg, J | 1 |
| O'Donnell, JJ | 2 |
| Whitmore, PV | 1 |
| Miner, RD | 1 |
| Parenti, D | 1 |
| MacGregor, RR | 1 |
| Graziani, AL | 1 |
| Weiss, R | 1 |
| Grunwald, JE | 1 |
| Palestine, AG | 1 |
| De Smet, MD | 1 |
| Baird, BF | 1 |
| Falloon, J | 1 |
| Kovacs, JA | 1 |
| Davey, RT | 1 |
| Zurlo, JJ | 1 |
| Zunich, KM | 1 |
| Davis, M | 1 |
| Marwick, C | 1 |
| Nightingale, SL | 1 |
| Nelson, MR | 1 |
| Barter, G | 1 |
| Hawkins, D | 1 |
| Gazzard, BG | 1 |
| Henderly, DE | 1 |
| Minor, JR | 1 |
| Baltz, JK | 1 |
| Farese, RV | 1 |
| Schambelan, M | 1 |
| Hollander, H | 1 |
| Stringari, S | 1 |
| Deray, G | 1 |
| Katlama, C | 1 |
| Dohin, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure[NCT00000691] | Phase 2 | 156 participants | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
10 reviews available for foscarnet and Eye Infections, Viral
| Article | Year |
|---|---|
Bilateral central retinal artery occlusion associated with herpes simplex virus-associated acute retinal necrosis and meningitis: case report and literature review.
Topics: Antibodies, Viral; Antiviral Agents; Aqueous Humor; DNA, Viral; Drug Therapy, Combination; Eye Infec | 2015 |
Diagnosis and Treatment of Acute Retinal Necrosis: A Report by the American Academy of Ophthalmology.
Topics: Academies and Institutes; Acyclovir; Antiviral Agents; Aqueous Humor; Biomedical Technology; DNA, Vi | 2017 |
Clinical characteristics of acute HSV-2 retinal necrosis.
Topics: Acyclovir; Adult; Antiviral Agents; Aqueous Humor; Child; DNA, Viral; Drug Therapy, Combination; Eye | 2004 |
Retinal disease associated with AIDS.
Topics: AIDS-Related Opportunistic Infections; CD4-Positive T-Lymphocytes; Cytomegalovirus Infections; Eye I | 1993 |
Characteristics of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Vi | 1992 |
Maintenance therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: foscarnet.
Topics: Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Eye Infections, Viral; Fosc | 1992 |
Cytomegalovirus retinitis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Diagnosis, Differe | 1992 |
Approaches to the treatment of cytomegalovirus retinitis: ganciclovir and foscarnet.
Topics: Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Eye Infections, Viral; Fosc | 1991 |
Diagnosis and treatment of cytomegalovirus retinitis.
Topics: Antiviral Agents; Cytomegalovirus Infections; Diagnosis, Differential; Eye Infections, Viral; Foscar | 1991 |
Foscarnet sodium.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Vi | 1991 |
2 trials available for foscarnet and Eye Infections, Viral
| Article | Year |
|---|---|
Design of a randomized controlled trial of foscarnet in patients with cytomegalovirus retinitis associated with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Eye Infecti | 1992 |
A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Eye Infecti | 1991 |
47 other studies available for foscarnet and Eye Infections, Viral
| Article | Year |
|---|---|
Inhibition of herpes simplex virus thymidine kinases by 2-phenylamino-6-oxopurines and related compounds: structure-activity relationships and antiherpetic activity in vivo.
Topics: Animals; Antiviral Agents; Cloning, Molecular; Encephalitis, Herpes Simplex; Eye Infections, Viral; | 2005 |
Acute Retinal Necrosis: Virological Features Using Quantitative Polymerase Chain Reaction, Therapeutic Management, and Clinical Outcomes.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Aqueous Humor; Cytomegalovirus Retinitis; DNA, Vir | 2019 |
Detection of Pre-clinical Involvement of the Second Eye in Viral Acute Retinal Necrosis Using Optical Coherence Tomography.
Topics: Eye Infections, Viral; Foscarnet; Herpesvirus 3, Human; Humans; Male; Middle Aged; Retinal Necrosis | 2022 |
ACUTE RETINAL NECROSIS: Difference in Outcome by Viral Type and Options for Antiviral Therapy.
Topics: Acyclovir; Adult; Aged; Aged, 80 and over; Antiviral Agents; DNA, Viral; Eye Infections, Viral; Fema | 2021 |
Sudden Unilateral Decrease in Vision in a Healthy Middle-aged Man.
Topics: Antiviral Agents; Eye Infections, Viral; Fluorescein Angiography; Foscarnet; Herpes Simplex; Herpesv | 2018 |
Case Report: Varicella-zoster Encephalitis with Acute Retinal Necrosis and Oculomotor Nerve Palsy.
Topics: Aged; Antiviral Agents; Aqueous Humor; Cerebrospinal Fluid; Drug Therapy, Combination; Encephalitis, | 2019 |
Acute retinal necrosis in a patient with remote severe herpes simplex encephalitis.
Topics: Acute Disease; Acyclovir; Antiviral Agents; Diagnosis, Differential; Encephalitis, Herpes Simplex; E | 2019 |
Acute retinal necrosis secondary to cytomegalovirus following successful treatment of cytomegalovirus anterior uveitis in an immunocompetent adult.
Topics: Antiviral Agents; Aqueous Humor; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Drug Thera | 2013 |
Acute retinal necrosis secondary to multidrug-resistant herpes simplex virus 2 in an immunocompetent adolescent.
Topics: Adolescent; Antiviral Agents; Drug Resistance, Viral; Eye Infections, Viral; Foscarnet; Herpes Simpl | 2014 |
Chorioretinitis with exudative retinal detachment secondary to varicella zoster virus.
Topics: Acyclovir; Administration, Oral; Antiviral Agents; Chorioretinitis; Drug Combinations; Exudates and | 2015 |
Intravitreal Foscarnet With Concurrent Silicone Oil Tamponade for Rhegmatogenous Retinal Detachment Secondary to Viral Retinitis.
Topics: Antiviral Agents; Combined Modality Therapy; Endotamponade; Eye Infections, Viral; Foscarnet; Humans | 2016 |
Treatment of Refractory Acute Retinal Necrosis with Intravenous Foscarnet or Cidofovir.
Topics: Aged; Aged, 80 and over; Antiviral Agents; Cidofovir; Cytosine; Eye Infections, Viral; Foscarnet; He | 2018 |
Acute retinal necrosis.
Topics: Acyclovir; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Eye Infections, Viral; Foscarnet | 2008 |
Acute retinal necrosis: the effects of intravitreal foscarnet and virus type on outcome.
Topics: Acyclovir; Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Eye Infections, Vira | 2010 |
Long-term follow-up of acute retinal necrosis.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Cytomegalovirus; Cytomegalovirus Infections; Drug | 2010 |
Herpes simplex virus type 1 encephalitis associated with acute retinal necrosis syndrome in an immunocompetent patient.
Topics: Adult; Antiviral Agents; Aqueous Humor; Cerebrospinal Fluid; DNA, Viral; Encephalitis, Herpes Simple | 2002 |
[Acute retinal necrosis: clinical presentation, treatment, and prognosis in a series of 22 patients].
Topics: Acyclovir; Adolescent; Adult; Aged; Antiviral Agents; Cytomegalovirus Retinitis; Drug Therapy, Combi | 2004 |
Bilateral optic neuropathy and unilateral tonic pupil associated with acute human herpesvirus 6 infection: a case report.
Topics: Adult; Antibodies, Viral; Antiviral Agents; Eye Infections, Viral; Foscarnet; Herpesvirus 6, Human; | 2005 |
Diagnosis and treatment of cytomegalovirus iridocyclitis without retinal necrosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Chronic Disease; Cytomegalovirus; Cyto | 2006 |
Intraocular sustained drug release devices.
Topics: AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Delayed-Action Preparations; Drug | 1995 |
Intravitreal foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome.
Topics: AIDS-Related Opportunistic Infections; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; | 1993 |
Foscarnet treatment in various cytomegalovirus infections.
Topics: Acquired Immunodeficiency Syndrome; Colitis; Cytomegalovirus Infections; Eye Infections, Viral; Fiss | 1993 |
Pathophysiology and treatment of clinically resistant cytomegalovirus retinitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus; Cytomegalovirus Infections; Drug Resi | 1993 |
Cytomegalovirus papillitis in patients with acquired immune deficiency syndrome. Visual prognosis of patients treated with ganciclovir and/or foscarnet.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; Cytomega | 1996 |
Management of varicella zoster virus retinitis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; AIDS-Related Opportunistic Infections; Analysi | 1997 |
Drugs for non-HIV viral infections.
Topics: 2-Aminopurine; Abnormalities, Drug-Induced; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Cont | 1997 |
Treatment of herpes retinitis in an animal model with a sustained delivery antiviral drug, liposomal 1-O-octadecyl-SN-glycerol-3-phosphonoformate.
Topics: Animals; Antiviral Agents; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Eye I | 1999 |
Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections.
Topics: Adult; Antiviral Agents; Cidofovir; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Cytos | 2001 |
From the National Institutes of Health.
Topics: Acquired Immunodeficiency Syndrome; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Arthr | 1992 |
Foscarnet.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Vi | 1992 |
Clinical implications of herpesvirus infections in patients with AIDS. Introduction.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Vi | 1992 |
Treatment of cytomegalovirus retinitis--1992.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Vi | 1992 |
Why was treatment of cytomegalovirus retinitis randomized?
Topics: Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; | 1992 |
Atypical healing of cytomegalovirus retinitis. Significance of persistent border opacification.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections | 1992 |
Visual field testing in the management of cytomegalovirus retinitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; Eye Infe | 1992 |
Intravitreal foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Cytomegalovirus Infections; Eye Infections, Viral; Follow | 1992 |
2.5 years survival with sequential ganciclovir/foscarnet treatment in a patient with acquired immune deficiency syndrome and cytomegalovirus retinitis.
Topics: AIDS-Related Opportunistic Infections; Cataract Extraction; Cytomegalovirus Infections; Drug Adminis | 1992 |
Opportunistic intraocular infections in AIDS.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Child; Child, Preschool; Choroiditis; Cyto | 1992 |
Treatment of CMV retinitis.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Vi | 1992 |
Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infect | 1991 |
Successful foscarnet therapy for cytomegalovirus retinitis in an AIDS patient undergoing hemodialysis: rationale for empiric dosing and plasma level monitoring.
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adult; Antiviral Agents; Cytomegalovirus In | 1991 |
National Eye Institute issues clinical alert about CMV retinitis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Vi | 1991 |
From the Food and Drug Administration.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Vi | 1991 |
Simultaneous treatment of cytomegalovirus retinitis with ganciclovir and foscarnet.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Eye Infecti | 1991 |
Seeing the way forward for treatment of CMV retinitis.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Infe | 1991 |
Nephrogenic diabetes insipidus associated with foscarnet treatment of cytomegalovirus retinitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Diabetes In | 1990 |
Prevention of foscarnet nephrotoxicity.
Topics: Adult; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Female; Fluid Therapy; F | 1990 |